Skip to main content
Log in

Which Antirheumatic Drug?

  • Practical Theraputic
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Successful therapy in a chronic rheumatic disease means choosing the right drug for the right patient with the right condition at the right time. In the treatment of gout three different types of treatment are given: for the acute episode, suppression and long-term therapy. Misuse of long-term therapy for acute gout will often aggravate the condition. As regards rheumatoid arthritis, in the absence of a known aetiology, treatment is essentially empirical and palliative; the use of milder well-tolerated anti-inflammatory agents for the less severe cases, more effective and more toxic agents for the more severe cases, and slow acting long-term agents for those not responding to previous measures is discussed. Night pain and morning stiffness has its own therapy. The place of corticosteroids throughout the whole field of rheumatology is evaluated. In the treatment of systemic lupus erythematosus corticosteroids still hold first place, but the cytotoxic (immunosuppressive) agents also play a part, though an arguable one.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Aylward, M.: Ginical studies on alclofenac in the treatment of rheumatic diseases. A drug in question. Current Medical Research and Opinion 3: 274 (1975)

    Article  CAS  Google Scholar 

  • Boardman, P.L. and Hart, F.D.: Indomethacin in the treatment of acute gout. Practitioner 194: 560 (1964).

    Google Scholar 

  • Decker, J.L.: Cytotoxic agents in the management of systemic lupus erythematosus. Clinics in Rheumatic diseases 1: 665 (1975).

    Google Scholar 

  • Hahn, B.H.; Kantor, O.S. and Osterland, C.K.: Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Annals of Internal Medicine 83: 597 (1975).

    PubMed  CAS  Google Scholar 

  • Hart, F.D.: Inflammatory disease and its control in rheumatic diseases. British Medical Journal 4: 191 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Hill, H.F.H. and Hill, A.G.S.: Naproxen in ankylosing spondylitis. Scandinavian Journal of Rheumatology (Supplement 2): 121 (1973).

  • Hunter, T.; Urowitz, M.B.; Gordon, D.A.; Smythe, H.A. and Ogryzlo, M.A.: Azathioprine in rheumatoid arthritis: A long term follow-up study. Arthritis and Rheumatism 18: 15 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Huskisson, E.C.: Rheumatology: Current concepts. In press (1975).

  • Urowitz, M.B.: Immunosuppressive therapy in rheumatoid arthritis. The Journal of Rheumatology 1: 364 (1974).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hart, F.D. Which Antirheumatic Drug?. Drugs 11, 451–460 (1976). https://doi.org/10.2165/00003495-197611060-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-197611060-00005

Keywords

Navigation